Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
2008
|